SFC
BIIB icon

SYM Financial Corp’s Biogen BIIB Stock Holding History

SYM Financial Corp’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$211K Buy
+1,150
New +$212K 0.02% 301
2025
Q4 		– Sell
-1,695
Closed -$237K – 425
2025
Q3 		$237K Buy
+1,695
New +$229K 0.03% 268

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SYM Financial Corp's BIIB Position: Q1 2026 in Review

SYM Financial Corp opened a new position in Biogen (BIIB) in Q1 2026: 1,150 shares worth $211K. The stake represents 0.02% of the portfolio and ranks #301 among its holdings. This is a return to the name: SYM Financial Corp previously reported a position in BIIB as recently as Q3 2025.

SYM Financial Corp first reported a position in BIIB in Q3 2025 and has held it in 2 quarters since. The position peaked at $237K in Q3 2025. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • SYM Financial Corp held 1,150 shares of Biogen worth $211K as of Q1 2026.
  • Biogen was a new SYM Financial Corp position in Q1 2026.
  • Biogen made up 0.02% of SYM Financial Corp's portfolio in Q1 2026, its #301 holding.
  • SYM Financial Corp first reported a position in Biogen in Q3 2025 and has held it in 2 quarters since.
  • SYM Financial Corp's Biogen position peaked at $237K in Q3 2025.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on SYM Financial Corp's 13F filing for Q1 2026, filed 8 May 2026.